<DOC>
	<DOCNO>NCT00457340</DOCNO>
	<brief_summary>To assess patient CAD [ coronary artery disease ] implantable defibrillator effect atorvastatin 80 mg versus placebo first recurrence ventricular arrhythmia ( ventricular tachycardia ventricular fibrillation require ICD [ implantable cardioverter defibrillator ] intervention ) within one year randomization .</brief_summary>
	<brief_title>Atorvastatin For The Reduction Of Ventricular Arrhythmias</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Eligible subject male female subject , age &gt; 18 year , clinically document coronary artery disease lifethreatening ventricular arrhythmia meet follow criterion : Were schedule ICD implantation ICD implantation within 1 month , accord class I American College Cardiology/American Heart Association ( ACC/AHA ) practice guideline ICD therapy OR Were already treat ICD class I ACC/AHA indication one month , provide receive least one appropriate ICD intervention ( shock antitachycardia pacing ( ATP ) ventricular tachycardia ventricular fibrillation ) precede six month Patients ventricular arrhythmia acute phase myocardial infarction ( first 48 hour ) . Patients incessant ventricular tachycardia . Patients ventricular arrhythmia without underlie coronary artery disease . Patients transient reversible cause ventricular arrhythmia ( include significant electrolyte disturbance drug induce proarrhythmia ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Tachycardia , Ventricular</keyword>
	<keyword>Ventricular Fibrillation</keyword>
</DOC>